SBC Medical Group Holdings Inco (SBC) Fair Value 2026

SBC · Services-Offices & Clinics of Doctors of Medicine ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.6 /10

32 fundamental signals · 13 models active

Value Trap Risk

SAFE (6/100)

Quick Summary — As of 2026-07-13, SBC Medical Group Holdings Inco (SBC) trades at $3.10, approximately 18% below CirclFi’s Bayesian DCF fair value of $3.79. QOC: 8.6/10. Value Trap Risk: 6/100 (SAFE). 13/13 models active.

Key Facts

Ticker
SBC
Price
$3.10
Quality Score
8.6/10
Value Trap Risk
6/100
Models Active
13/13
Last Updated
Strength: Earnings Power Value suggests +78.4% upside with 56% confidence
Risk: Limited model coverage (13/13) may reduce confidence

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($3.10)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$3.79 +22.3%
Earnings Power Value
High Conviction
$5.53 +78.4%
CUCE Ensemble
Medium Conviction
$3.51 +13.3%
First Chicago
Medium Conviction
$4.42 +42.7%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is SBC Medical Group Holdings Inco (SBC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on SBC Medical Group Holdings Inco at $3.10. With an estimated intrinsic value of $3.51 and 9 of 13 models pointing higher, the average implied return is +13.3%. The most optimistic model, EPV, places fair value at $5.53 (+78.4%), while Markov DDM — the most conservative — estimates $0.89 (-71.3%). This +149.8% gap reflects genuine analytical uncertainty about SBC Medical Group Holdings Inco's intrinsic worth.

What Do the Models Say About SBC?

13 of 13 models are currently active for SBC. Of these, 9 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates SBC's intrinsic value at $3.79, implying +22.3% upside from the current price. See which stocks rank higher →

How Does SBC Rank in Services-Offices & Clinics of Doctors of Medicine?

Among 8 Services-Offices & Clinics of Doctors of Medicine stocks, SBC ranks #1 by Quality of Company score. CirclFi's QOC score of 8.6/10 evaluates 32 fundamental signals. A score of 8.6 places SBC in the top tier.

SBC Medical Group Holdings Inco operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is SBC a Value Trap?

CirclFi's Value Trap algorithm assigns SBC a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for SBC Medical Group Holdings Inco. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, SBC Medical Group Holdings Inco earns a quality score of 8.6/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +149.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SBC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SBC's 13 active models, average confidence is 44%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy SBC Medical Group Holdings Inco Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Offices & Clinics of Doctors of Medicine Stocks Should You Also Analyze?

7 related Services-Offices & Clinics of Doctors of Medicine stocks with 13-model coverage

Read investment analysis: BMGL · TDOC · HIMS · AUNA · LFMD

Frequently Asked Questions About SBC Medical Group Holdings Inco

What is SBC Medical Group Holdings Inco's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, SBC Medical Group Holdings Inco (SBC) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $3.79. The Quality of Company score is 8.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SBC overvalued or undervalued right now?

At $3.10, 9 of 13 active models suggest SBC may be undervalued, while 4 indicate potential overvaluation. The assessment depends on which methodology best fits SBC Medical Group Holdings Inco's business model in Services-Offices & Clinics of Doctors of Medicine.

What does a Quality of Company score of 8.6 mean for SBC?

SBC Medical Group Holdings Inco's QOC of 8.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on SBC?

CirclFi analyzes SBC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is SBC a value trap in 2026?

SBC Medical Group Holdings Inco's Value Trap score is 6/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on SBC.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access